losartan has been researched along with Alveolar Bone Atrophy in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Excerpt | Relevance | Reference |
---|---|---|
"Mice were subjected to Aggregatibacter actinomycetemcomitans oral infection or antigen-induced arthritis and treated daily with 10 mg/kg of the prototype AT1 antagonist, losartan." | 7.81 | Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss. ( da Silva, TA; de Oliveira, CR; Ferreira, AJ; Fukada, SY; Madeira, MF; Moura, AP; Queiroz-Junior, CM; Silveira, KD; Soriani, FM; Souza, DG; Teixeira, MM, 2015) |
"Mice were subjected to Aggregatibacter actinomycetemcomitans oral infection or antigen-induced arthritis and treated daily with 10 mg/kg of the prototype AT1 antagonist, losartan." | 3.81 | Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss. ( da Silva, TA; de Oliveira, CR; Ferreira, AJ; Fukada, SY; Madeira, MF; Moura, AP; Queiroz-Junior, CM; Silveira, KD; Soriani, FM; Souza, DG; Teixeira, MM, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Queiroz-Junior, CM | 1 |
Silveira, KD | 1 |
de Oliveira, CR | 1 |
Moura, AP | 1 |
Madeira, MF | 1 |
Soriani, FM | 1 |
Ferreira, AJ | 1 |
Fukada, SY | 1 |
Teixeira, MM | 1 |
Souza, DG | 1 |
da Silva, TA | 1 |
1 other study available for losartan and Alveolar Bone Atrophy
Article | Year |
---|---|
Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss.
Topics: Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Arthri | 2015 |